| Trial | Updated / Type |
Status | Phase | Were Results Reported |
Reported Actual Enrollment |
(MeSH) Terms |
Why Stopped
Limitations And Caveats |
Annotator decisions |
|---|---|---|---|---|---|---|---|---|
| NCT01925612 Details | 2018-06-21 Interventional | 2 | 87 | Antibodies, Mon… Brentuximab Ved… Cyclophosphamid… Doxorubicin Prednisone Rituximab Vincristine Lymphoma Lymphoma, B-Cel… Lymphoma, Large… Lymphoma, B-cel… Lymphoma, Large… | Sponsor decision based on portfolio prioritization and changing treatment landscape in
frontline DLBCL - | |||
| NCT02015637 Details | 2018-06-20 Interventional | 3 | 460 | Ceftriaxone Delafloxacin Gonorrhea | - - | |||
| NCT01929317 Details | 2018-06-20 Interventional | 3 | 81 | Ropinirole Parkinson Disea… | - - | |||
| NCT03149159 Details | 2018-06-18 Interventional | 2 | 0 | Ipilimumab Nivolumab Carcinoma Carcinoma, Rena… Clear Cell Rena… Metastatic Rena… | This study is withdrawn due to feasibility issues. - | |||
| NCT02712775 Details | 2018-06-18 Interventional | 4 | 0 | Minocycline Liver Diseases Liver Disease | Study logistics - | |||
| NCT00262132 Details | 2018-06-18 Interventional | 3 | - | Mycophenolic Ac… Sarcoidosis Sarcoidosis, Pu… Pulmonary Sarco… | - - | |||
| NCT02702960 Details | 2018-06-15 Interventional | 2 | 0 | Antilymphocyte … Cyclophosphamid… Fludarabine Mesna Mycophenolic Ac… Prednisone Tacrolimus Carcinoma Carcinoma, Hepa… Fibrolamellar H… Hepatocellular … Hepatocellular … | This study was withdrawn due to lack of necessary resources from the liver transplant surgical
group. - | |||
| NCT02532010 Details | 2018-06-15 Interventional | 2 | 13 | Cytarabine Decitabine Leukemia Leukemia, Myelo… Leukemia, Myelo… Acute Myeloid L… | The study was put on clinical hold by the sponsor since Feb 9th 2016, and was later decided not
to re-open due to financial constraints. - | |||
| NCT02204722 Details | 2018-06-15 Interventional | 4 | 55 | Imatinib Mesyla… Leukemia Leukemia, Myelo… Leukemia, Myelo… Chronic Myeloid… | Sponsor's decision to halt the study. - | |||
| NCT00403780 Details | 2018-06-15 Interventional | 4 | 18 | Pregabalin Arterial Occlus… Chronic Limb-Th… Ischemia Arterial Occlus… Critical Limb I… Pain | low inclusion rate - | |||
| NCT03059277 Details | 2018-06-14 Interventional | 4 | 0 | Aflibercept Edema Macular Edema Diabetic Macula… | Site investigator decided to not move forward with study. - | |||
| NCT02203630 Details | 2018-06-13 Interventional | 4 | 17 | Norepinephrine Oxymetazoline Phenylephrine Arrhythmias, Ca… Shock Shock, Septic Tachycardia Arrhythmia Sepsis Septic Shock | Slow enrollment; Lack of support and equipoise Study was terminated early due to slow enrollment, lack of support and equipoise. PI left Vanderbilt and the record was completed with data recorded in REDCap. | |||
| NCT01183468 Details | 2018-06-13 Interventional | 1 | 17 | Alpha 1-Antitry… Protein C Inhib… Diabetes Mellit… Diabetes Mellit… | Due to lack of mechanistic signal and competing industry studies This (Part 1) was the drug dosing portion of the study; however, due to lack of a mechanistic signal and competing industry studies, the study was terminated and the trial portion (Part II, NCT01183455) was withdrawn. | |||
| NCT00059228 Details | 2018-06-13 Interventional | 2 | 12 | Estradiol Estradiol 17 be… Estradiol 3-ben… Polyestradiol p… Depression Depression, Pos… Depressive Diso… Postpartum Depr… | - - | |||
| NCT03110900 Details | 2018-06-11 Interventional | 4 | 2 | Haloperidol Haloperidol dec… Lorazepam Loxapine Psychomotor Agi… Agitation,Psych… Haloperidol Cau… Lorazepam Causi… Loxapine Causin… | Sponsor Withdrawal - | |||
| NCT01661322 2007-006749-42 Details | 2018-06-11 Interventional | 3 | 3096 | Aspirin Clopidogrel Ischemic Stroke Stroke | Trial reached a definitive answer ahead of full recruitment. - | |||
| NCT03105349 Details | 2018-06-08 Interventional | 4 | 0 | Elbasvir-grazop… Grazoprevir Ribavirin Sofosbuvir Hepatitis C Hepatitis C, Ch… HCV | No availability of investigational medication. - | |||
| NCT00955305 Details | 2018-06-06 Interventional | 2 | [1 Refs] | 175 | Bevacizumab Carboplatin Paclitaxel Adenocarcinoma … Adenocarcinoma,… Carcinoma Carcinoma, Non-… Lung Neoplasms Bronchioloalveo… Large Cell Lung… Lung Adenocarci… Recurrent Non-S… Stage IV Non-Sm… | The study was closed to accrual due to the end of the clinical development program with
cixutumumab. - | ||
| NCT03183596 Details | 2018-05-31 Interventional | 3 | 0 | Bupivacaine Dexamethasone Pain, Postopera… | Principal investigator determination - | |||
| NCT02705872 Details | 2018-05-31 Interventional | 2 | 0 | Dsuvia Levobupivacaine Sufentanil First Child Del… | Change in guidelines - |